The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Plerixafor (INN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients into the bloodstream.
The global Plerixafor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Plerixafor is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Plerixafor is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Plerixafor in Non-Hodgkin's lymphoma (NHL) Patients is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Plerixafor include sanofi-aventis. etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Plerixafor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plerixafor.
Report Scope
The Plerixafor market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plerixafor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plerixafor companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
sanofi-aventis
Segment by Type
24MG/1.2ML
Type II
Segment by Application
Non-Hodgkin's lymphoma (NHL) Patients
Multiple myeloma (MM) Patients
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plerixafor companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Plerixafor (INN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients into the bloodstream.
The global Plerixafor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Plerixafor is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Plerixafor is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Plerixafor in Non-Hodgkin's lymphoma (NHL) Patients is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Plerixafor include sanofi-aventis. etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Plerixafor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plerixafor.
Report Scope
The Plerixafor market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plerixafor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plerixafor companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
sanofi-aventis
Segment by Type
24MG/1.2ML
Type II
Segment by Application
Non-Hodgkin's lymphoma (NHL) Patients
Multiple myeloma (MM) Patients
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plerixafor companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plerixafor Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 24MG/1.2ML
1.2.3
1.3 Market by Application
1.3.1 Global Plerixafor Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Non-Hodgkin's lymphoma (NHL) Patients
1.3.3 Multiple myeloma (MM) Patients
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plerixafor Market Perspective (2019-2030)
2.2 Plerixafor Growth Trends by Region
2.2.1 Global Plerixafor Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Plerixafor Historic Market Size by Region (2019-2024)
2.2.3 Plerixafor Forecasted Market Size by Region (2025-2030)
2.3 Plerixafor Market Dynamics
2.3.1 Plerixafor Industry Trends
2.3.2 Plerixafor Market Drivers
2.3.3 Plerixafor Market Challenges
2.3.4 Plerixafor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plerixafor Players by Revenue
3.1.1 Global Top Plerixafor Players by Revenue (2019-2024)
3.1.2 Global Plerixafor Revenue Market Share by Players (2019-2024)
3.2 Global Plerixafor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plerixafor Revenue
3.4 Global Plerixafor Market Concentration Ratio
3.4.1 Global Plerixafor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plerixafor Revenue in 2023
3.5 Plerixafor Key Players Head office and Area Served
3.6 Key Players Plerixafor Product Solution and Service
3.7 Date of Enter into Plerixafor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plerixafor Breakdown Data by Type
4.1 Global Plerixafor Historic Market Size by Type (2019-2024)
4.2 Global Plerixafor Forecasted Market Size by Type (2025-2030)
5 Plerixafor Breakdown Data by Application
5.1 Global Plerixafor Historic Market Size by Application (2019-2024)
5.2 Global Plerixafor Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Plerixafor Market Size (2019-2030)
6.2 North America Plerixafor Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Plerixafor Market Size by Country (2019-2024)
6.4 North America Plerixafor Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plerixafor Market Size (2019-2030)
7.2 Europe Plerixafor Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Plerixafor Market Size by Country (2019-2024)
7.4 Europe Plerixafor Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plerixafor Market Size (2019-2030)
8.2 Asia-Pacific Plerixafor Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Plerixafor Market Size by Region (2019-2024)
8.4 Asia-Pacific Plerixafor Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plerixafor Market Size (2019-2030)
9.2 Latin America Plerixafor Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Plerixafor Market Size by Country (2019-2024)
9.4 Latin America Plerixafor Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plerixafor Market Size (2019-2030)
10.2 Middle East & Africa Plerixafor Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Plerixafor Market Size by Country (2019-2024)
10.4 Middle East & Africa Plerixafor Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 sanofi-aventis
11.1.1 sanofi-aventis Company Detail
11.1.2 sanofi-aventis Business Overview
11.1.3 sanofi-aventis Plerixafor Introduction
11.1.4 sanofi-aventis Revenue in Plerixafor Business (2019-2024)
11.1.5 sanofi-aventis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Plerixafor Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 24MG/1.2ML
Table 3. Key Players of Type II
Table 4. Global Plerixafor Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Plerixafor Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Plerixafor Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Plerixafor Market Share by Region (2019-2024)
Table 8. Global Plerixafor Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Plerixafor Market Share by Region (2025-2030)
Table 10. Plerixafor Market Trends
Table 11. Plerixafor Market Drivers
Table 12. Plerixafor Market Challenges
Table 13. Plerixafor Market Restraints
Table 14. Global Plerixafor Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Plerixafor Market Share by Players (2019-2024)
Table 16. Global Top Plerixafor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plerixafor as of 2023)
Table 17. Ranking of Global Top Plerixafor Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Plerixafor Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Plerixafor Product Solution and Service
Table 21. Date of Enter into Plerixafor Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Plerixafor Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Plerixafor Revenue Market Share by Type (2019-2024)
Table 25. Global Plerixafor Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Plerixafor Revenue Market Share by Type (2025-2030)
Table 27. Global Plerixafor Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Plerixafor Revenue Market Share by Application (2019-2024)
Table 29. Global Plerixafor Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Plerixafor Revenue Market Share by Application (2025-2030)
Table 31. North America Plerixafor Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Plerixafor Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Plerixafor Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Plerixafor Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Plerixafor Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Plerixafor Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Plerixafor Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Plerixafor Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Plerixafor Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Plerixafor Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Plerixafor Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Plerixafor Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Plerixafor Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Plerixafor Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Plerixafor Market Size by Country (2025-2030) & (US$ Million)
Table 46. sanofi-aventis Company Detail
Table 47. sanofi-aventis Business Overview
Table 48. sanofi-aventis Plerixafor Product
Table 49. sanofi-aventis Revenue in Plerixafor Business (2019-2024) & (US$ Million)
Table 50. sanofi-aventis Recent Development
Table 51. Research Programs/Design for This Report
Table 52. Key Data Information from Secondary Sources
Table 53. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plerixafor Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Plerixafor Market Share by Type: 2023 VS 2030
Figure 3. 24MG/1.2ML Features
Figure 4. Type II Features
Figure 5. Global Plerixafor Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Plerixafor Market Share by Application: 2023 VS 2030
Figure 7. Non-Hodgkin's lymphoma (NHL) Patients Case Studies
Figure 8. Multiple myeloma (MM) Patients Case Studies
Figure 9. Plerixafor Report Years Considered
Figure 10. Global Plerixafor Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Plerixafor Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Plerixafor Market Share by Region: 2023 VS 2030
Figure 13. Global Plerixafor Market Share by Players in 2023
Figure 14. Global Top Plerixafor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plerixafor as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Plerixafor Revenue in 2023
Figure 16. North America Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Plerixafor Market Share by Country (2019-2030)
Figure 18. United States Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Plerixafor Market Share by Country (2019-2030)
Figure 22. Germany Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Plerixafor Market Share by Region (2019-2030)
Figure 30. China Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Plerixafor Market Share by Country (2019-2030)
Figure 38. Mexico Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Plerixafor Market Share by Country (2019-2030)
Figure 42. Turkey Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. sanofi-aventis Revenue Growth Rate in Plerixafor Business (2019-2024)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
